OptimizeRx CorporationOPRXNASDAQ
Loading
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P21
Within normal range
Average
19.49%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 0.00% |
| 2024 | 0.00% |
| 2023 | 0.00% |
| 2022 | 0.00% |
| 2021 | 0.00% |
| 2020 | -100.00% |
| 2019 | 137.43% |
| 2018 | -33.04% |
| 2017 | 153.27% |
| 2016 | 37.20% |